🔴 Biovie is trading 6.15% down in pre-market

Biovie is trading at $1.83, down -6.15% in pre-market, with the immediate reason unclear.

• No new company-specific announcement or earnings catalyst was identified for August 24, 2026.
• The latest major development remains positive Phase 2 SUNRISE-PD data announced August 6, showing statistically significant improvements versus placebo.
• Broader pre-market sentiment is cautious, but major-index declines are insufficient to establish a direct cause; recent volatility remains substantial.